Dr. Liao Yan of Beike Biotech R&D Center named Guangdong Province Enterprise "Innovation Star"
Recently, in line with the China Association for Science and Technology's plans for the 2022 Enterprise "Innovation Star" speaking campaign, the Guangdong……
Grand ribbon-cutting ceremony for Beike Biotech's new Class B clean facility at the Shenzhen Regional Cell Preparation Center
On 26 October 2022, Shenzhen Beike Biotechnology Co., Ltd.'s key 2022 project, the "new Class B clean facility at the Shenzhen (Beike) Regional Cell……
Another expert joins Beike Biotech! Professor Wang Zhihua of Fuwai Hospital, Chinese Academy of Medical Sciences, appointed as external expert
On 18 October 2022, Shenzhen Beike Biotechnology Co., Ltd. held an appointment ceremony and academic seminar for an external expert advisor. Dr.…
Good news! Beike Biotech signs strategic cooperation agreement with the People's Government of Yunnan Province!
On 28 September, Wang Yubo, Vice Party Secretary and Governor of Yunnan Province, held a working meeting in Kunming with Hu Junyuan, Chairman of Shenzhen……
Beike Biotech Publishes Featured Article in Nature Supplement "Nature Spotlight: Precision Medicine in China"
In 2016, the Chinese government formally incorporated precision medicine into the 13th Five-Year Plan, which greatly advanced domestic precision medicine……
Major news! Beike Biotech's Academician (Expert) Workstation approved for establishment
On June 27, 2022, the Shenzhen Association for Science and Technology issued a notice that, in accordance with the requirements of the Administrative and……
Boosting the digital life industry! Beike Biotech and the Heilongjiang Provincial Government sign a strategic cooperation agreement
On May 27, 2022, the Heilongjiang Provincial Government held a discussion meeting between the Heilongjiang Province and key bioeconomy enterprises.…
Major News! Organoids Listed for the First Time in CDE Guidelines for Gene Therapy and Cell Therapy
Recently, the Center for Drug Evaluation (CDE) of the National Medical Products Administration consecutively issued three guidelines related to gene……
Shenzhen Issues "1+3" Documents on Cluster Development of the Biopharmaceutical Industry; Up to RMB 300 Million Funding for Key Cell-Drug Technology!
Recently, in order to implement the policy spirit of the "Opinions of the CPC Central Committee and the State Council on Supporting Shenzhen in Building a……
Shenzhen issues '1+3' documents on the clustered development of the biopharmaceutical industry; key technology research on cell drugs eligible for up to 300 million yuan in funding!
Recently, in order to implement the policy spirit of documents such as the Opinions of the CPC Central Committee and the State Council on Supporting……
New Breakthrough in Umbilical Cord Mesenchymal Stem Cell Therapy for Bronchopulmonary Dysplasia! Dr. Liao Yan's Team at Beike Biotech R&D Center Publishes Latest Paper
The Beike Biotech R&D team, in collaboration with multiple medical institutions in Shenzhen, has carried out research on umbilical cord mesenchymal stem……
Latest news! The first stem cell clinical research project in China's plastic surgery specialty has been filed with the National Health Commission!
Stem cell research in China is accelerating, with another stem cell clinical research project filed with the National Health Commission.…